Tower Research Capital (TRC)’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,130
Closed -$30.7K 5189
2024
Q4
$30.7K Buy
4,130
+3,754
+998% +$27.9K ﹤0.01% 2888
2024
Q3
$3.57K Buy
+376
New +$3.57K ﹤0.01% 4818
2024
Q2
Sell
-1,640
Closed -$35.7K 5682
2024
Q1
$35.7K Sell
1,640
-126
-7% -$2.74K ﹤0.01% 2508
2023
Q4
$16.1K Buy
1,766
+1,559
+753% +$14.2K ﹤0.01% 3796
2023
Q3
$6.02K Buy
207
+148
+251% +$4.3K ﹤0.01% 4653
2023
Q2
$5.04K Buy
59
+49
+490% +$4.19K ﹤0.01% 4847
2023
Q1
$4K Buy
+10
New +$4K ﹤0.01% 5042
2022
Q4
Hold
0
5875
2022
Q3
Hold
0
6050
2022
Q2
Sell
-5
Closed -$11K 6062
2022
Q1
$11K Buy
5
+2
+67% +$4.4K ﹤0.01% 4142
2021
Q4
$13K Hold
3
﹤0.01% 4150
2021
Q3
$18K Buy
3
+1
+50% +$6K ﹤0.01% 3802
2021
Q2
$18K Sell
2
-2
-50% -$18K ﹤0.01% 3978
2021
Q1
$33K Buy
4
+2
+100% +$16.5K ﹤0.01% 3478
2020
Q4
$18K Sell
2
-9
-82% -$81K ﹤0.01% 3925
2020
Q3
$75K Buy
11
+9
+450% +$61.4K ﹤0.01% 3350
2020
Q2
$14K Sell
2
-1
-33% -$7K ﹤0.01% 3859
2020
Q1
$20K Buy
+3
New +$20K ﹤0.01% 1705
2019
Q4
Hold
0
3017
2019
Q3
Sell
-1
Closed -$8K 4076
2019
Q2
$8K Hold
1
﹤0.01% 2672
2019
Q1
$18K Hold
1
﹤0.01% 2316
2018
Q4
$7K Sell
1
-1
-50% -$7K ﹤0.01% 2668
2018
Q3
$24K Buy
+2
New +$24K ﹤0.01% 2209
2018
Q2
Hold
0
2993
2016
Q4
Hold
0
-$2K 3811
2016
Q3
Hold
0
3026
2016
Q2
Hold
0
-$3K 4412
2016
Q1
Hold
0
-$3K 3045
2015
Q4
Hold
0
3388